The study evaluating differences in dosing and clinical outcomes before and after Gla-300 treatment initiation in patients with type 2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 12 Jan 2018 New trial record
- 08 Jan 2018 Results published in the Advances in Therapy.